Skip to main content
. 2023 May 26;182(8):3619–3629. doi: 10.1007/s00431-023-05007-y

Table 6.

Comparison of characteristics of Continuous Renal Replacement Therapy in children according to survival status

Data Survivors (N = 27) Non-survivors (N = 24) P value
Hours of CRRT (Effective)a 120 (70, 384) 64.5 (16, 210) 0.045
Mean Filter life per Individual (hrs)b 43.48  ± 20.58 37.25  ± 22.92 0.311
CRRT catheter site, n (%)

Femoral vein (15.6%)

Internal jugular vein (76.4%)

Subclavian vein (7.84%)

6

21

0

(22.2)

(77.7)

(0)

2

18

4

(8.3)

(75)

(16.6)

0.048
CRRT catheter size, n (%)

6F (1.96%)

6.5F (82.35%)

8F (13.73%)

10F (1.96%)

1

21

4

1

(3.7)

(77.7)

(14.8)

(3.7)

0

21

3

0

(87.5)

(12.5)

1.000
Blood flow rate (mL/kg/min)a 8.80 (7.69, 12.50) 13.6 (7.71, 17.83) 0.054
CRRT dose (mL/kg/h)a 60 (51.5, 79) 60 (47, 66) 0.675
Anticoagulation, n (%)

    Prostacyclin

    Heparin

26

1

(96.3)

(3.7)

20

0

(83.3)

(0)

    No anticoagulant 0 (0) 4 (16.67) 0.043
Serum creatinine, μmol/La 51 (27, 170) 55.5 (38,89) 0.25
Serum urea, mmol/La 7.9 (5.4, 13.0) 6.75 (3.8, 17.2) 0.463
Base excess, mEq/Lb -5.33  ± 7.21 -6.44  ± 9.65 0.64
Serum lactate, mmol/La 4.5 (1.5, 7.8) 5.6 (2.61, 10.66) 0.183
Serum bicarbonate, mmol/La 20.90  ± 6.43 20.84  ± 8.40 0.982
Key indication for CRRT, n (%)

    Renal failure

    ALF

    High ammonia

    High lactate

    Fluid overload > 10%

    Multiple reasons

19 (70.4)

13 (48.1)

4 (14.8)

9 (33.3)

9 (33.3)

16 (59.3)

15 (62.5)

14 (58.3)

9 (37.5)

10 (41.7)

12 (50.0)

18 (75.0)

0.552

0.467

0.064

0.539

0.227

0.234

Primary diagnosis, n (%)
Acute liver failure 10 (37.0) 14 (58.3) 0.128
Chronic liver disease/biliary atresia 7 (25.9) 5 (20.8) 0.669
Sepsis  4 (14.8) 8 (33.3) 0.120
Inborn error of metabolism 7 (25.9) 7 (29.2) 0.796
Other 10 (37.0) 10 (41.7) 0.735 
*Some patients had multiple primary diagnoses

Bold denotes p<0.05

aMedian (IQR 25%, 75%)

bMean (SD)